LisleMNabellMD

Oncology • Birmingham, AL

Associate Professor of Medicine, University Alabama

Request Appointment

Overview of Dr. Nabell

Director, Hematology/Oncology Fellowship Training Program

Office
1717 6th Ave S
Birmingham, AL 35233
Book by Phone+1(659) 333-2491

Education & Training

University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
University of Alabama Medical CenterResidency, Internal Medicine, 1987 - 1990
University of North Carolina at Chapel Hill School of MedicineClass of 1987

Certifications & Licensure

AL State Medical License 1988 - 2024
NC State Medical License 1988 - 1990
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
America's Top Doctors for Cancer Castle Connolly, 2007-2013
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer Start of enrollment: 2000 Oct 01
Terminated
Phase 2
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer Start of enrollment: 2002 Oct 01
Completed
Phase 2
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2002 Oct 01
Completed
Phase 1, Phase 2
A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases Start of enrollment: 2011 Sep 01
Completed
Phase 2
Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures Start of enrollment: 2015 Nov 01
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

219 citations
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinica...
Lillian L. Siu, Caroline Even, Ricard Mesia, Éva Remenár, Amaury Daste
JAMA Oncology. 2019-02-01
32 citations
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal ...
Daniel W. Bowles, Mark D. Kochenderfer, Allen Lee Cohn, Lucas Sideris, Nghia Nguyen
Clinical Colorectal Cancer. 2016-12-01
230 citations
Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer
Jimmy J. Caudell, Philip E. Schaner, Ruby F. Meredith, Julie L. Locher, Lisle Nabell
International Journal of Radiation Oncology, Biology, Physics. 2009-02-01

Insurance Accepted

BCBS Alabama PPO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Humana ChoiceCare Network PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment